1. Home
  2. SRDX vs KFS Comparison

SRDX vs KFS Comparison

Compare SRDX & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • KFS
  • Stock Information
  • Founded
  • SRDX 1979
  • KFS 1989
  • Country
  • SRDX United States
  • KFS United States
  • Employees
  • SRDX N/A
  • KFS N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • KFS Property-Casualty Insurers
  • Sector
  • SRDX Health Care
  • KFS Finance
  • Exchange
  • SRDX Nasdaq
  • KFS Nasdaq
  • Market Cap
  • SRDX 415.4M
  • KFS 338.1M
  • IPO Year
  • SRDX 1998
  • KFS 1996
  • Fundamental
  • Price
  • SRDX $31.10
  • KFS $14.37
  • Analyst Decision
  • SRDX Buy
  • KFS
  • Analyst Count
  • SRDX 2
  • KFS 0
  • Target Price
  • SRDX $43.00
  • KFS N/A
  • AVG Volume (30 Days)
  • SRDX 89.7K
  • KFS 119.7K
  • Earning Date
  • SRDX 07-30-2025
  • KFS 08-05-2025
  • Dividend Yield
  • SRDX N/A
  • KFS N/A
  • EPS Growth
  • SRDX N/A
  • KFS N/A
  • EPS
  • SRDX N/A
  • KFS N/A
  • Revenue
  • SRDX $121,575,000.00
  • KFS $114,710,000.00
  • Revenue This Year
  • SRDX N/A
  • KFS N/A
  • Revenue Next Year
  • SRDX $3.70
  • KFS N/A
  • P/E Ratio
  • SRDX N/A
  • KFS N/A
  • Revenue Growth
  • SRDX N/A
  • KFS 6.75
  • 52 Week Low
  • SRDX $26.00
  • KFS $7.06
  • 52 Week High
  • SRDX $42.25
  • KFS $16.80
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 66.72
  • KFS 55.96
  • Support Level
  • SRDX $30.54
  • KFS $13.27
  • Resistance Level
  • SRDX $31.47
  • KFS $16.80
  • Average True Range (ATR)
  • SRDX 0.93
  • KFS 0.92
  • MACD
  • SRDX 0.21
  • KFS -0.10
  • Stochastic Oscillator
  • SRDX 95.58
  • KFS 44.75

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About KFS Kingsway Financial Services Inc. (DE)

Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.

Share on Social Networks: